Milestone Pharmaceuticals Inc.
MIST
$2.15
$0.073.37%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -11.92M | -12.97M | -20.76M | -12.36M | -9.44M |
| Total Depreciation and Amortization | 25.00K | 28.00K | 27.00K | 567.00K | 25.00K |
| Total Amortization of Deferred Charges | 109.00K | 106.00K | 102.00K | 97.00K | 95.00K |
| Total Other Non-Cash Items | 2.11M | 2.15M | 2.10M | 1.64M | 2.09M |
| Change in Net Operating Assets | -69.00K | -1.89M | 4.58M | 3.22M | 208.00K |
| Cash from Operations | -9.75M | -12.57M | -13.95M | -6.84M | -7.02M |
| Capital Expenditure | -2.00K | -11.00K | -6.00K | -22.00K | -4.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -34.98M | 9.96M | 33.59M | 19.36M | 6.49M |
| Cash from Investing | -34.98M | 9.94M | 33.58M | 19.33M | 6.48M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 46.35M | 36.00K | 140.00K | 24.00K | 74.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 2.57M | -- | -- | 0.00 | 0.00 |
| Cash from Financing | 48.92M | 36.00K | 140.00K | 24.00K | 74.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.19M | -2.59M | 19.77M | 12.52M | -463.00K |